Study of Utidelone Based Neoadjuvant Treatment on Early High-risk or Locally Advanced Breast Cancer
Clinical trial NCT05983094 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT05983094
- Sponsor
- Cancer Institute and Hospital, Chinese Academy of Medical Sciences
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-09-01
- Primary completion
- 2026-09-01
- Enrollment
- 181
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.